Here we demonstrate that the mRNA levels of TRIM25 are upregulated in a variety of cancer types including HCC and that upregulation of TRIM25 correlated with poor clinical outcome in patients with HCC as well as breast cancer and low grade glioma. This evidence concerns the gene TRIM25 and breast carcinoma.